Position in PTGX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$490
+$69 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#335
of 341 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DecisionPoint Financial, LLC holds $47,288 across 33 Biotechnology names. PTGX ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLTX |
MoonLake Immunotherapeutics
|
1,219 | $23,733 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16 | $9,976 | |
| 3 | MNKD |
Mannkind Corp
|
1,348 | $5,742 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2 | $993 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
11 | $956 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
22 | $809 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
This page
|
4 | $490 | |
| 8 | EXEL |
Exelixis, Inc.
|
9 | $489 |
All Filings in PTGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $490 | 4 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $421 | 4 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $349 | 4 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $265 | 4 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $221 | 4 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||